davidrind
June 4th, 2010
Composite Endpoints and the CREST Trial
davidrind
CardioExchange welcomes this guest post reprinted with permission from Dr. David Rind, an academic primary care physician and medical editor in Boston. This piece originally appeared on his blog, Evidence in Medicine. For more on the CREST trial, see the NEJM article and editorial, the Journal Watch summary by Dr. Howard Herrmann, and an Interventional Cardiology blog by Dr. […]
NEJM Journal Watch — Recent Cardiology Articles- Do GLP-1 Receptor Agonists Improve Walking Function in Patients with PAD and Claudication?
- Bleeding During Anticoagulation for Atrial Fibrillation and Subsequent Malignancy
- Revised Guidance for Athletes with Cardiovascular Disease: A Shift Toward Shared Decision Making
- Is a Traditional 5-to-7–Day Hold of Ticagrelor Necessary Prior to CABG?
- New Recommendations for Antithrombotic Therapy in Patients with Acute Coronary Syndromes